Menu
My Activity Hub
Podcasts
Videos
Pricing
Feedback
Tutoring
Sign Up
Log In
My Activity Hub
Podcasts
Videos
How it works
Pricing
Tutoring
Sign Up
Log In
CME
Do Not Delay: Timing, Triggers, and Identifying the Right Patient for Additional Therapies in HFrEF
7 mins; February 12, 2026
Evidence at a Glance: The Totality of Evidence Impacting Clinical Decision-Making in Patients with HFrEF Without a Recent Worsening Event
5 mins; February 12, 2026
GDMT Is Working Fine, Why Add More Therapies? The Clinical Rationale for Layering Therapies in Patients with HFrEF
6 mins; February 12, 2026
Safety, Clinical Integration, and the Emerging Fifth Pillar in HF Practice
6 mins; February 12, 2026
When GDMT Isn’t Enough: Understanding Residual Risk in Patients with HFrEF
7 mins; February 12, 2026
GDMT Is Working Fine, so Why Add More Therapies for Patients With HFrEF?
14 mins; February 09, 2026
Targeting B7-H3 in ES-SCLC: Advancing Targeted Therapy Through Evidence-Based Innovation and Multidisciplinary Care
13 mins; February 09, 2026
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
16 mins; January 29, 2026
Advancing Care in HNSCC: Evolving Strategies Across the Disease Continuum
25 mins; January 29, 2026
Double-Class Refractory CLL in Community Practice: Current and Future Management
13 mins; January 29, 2026
From Late-Line Rescue to Early-Line Option: The Potential for Bispecific Antibodies in Multiple Myeloma
16 mins; January 29, 2026
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
10 mins; January 29, 2026
Missing the Window in Ambulatory Patients With HFrEF on GDMT: Strategies for CV Risk Reduction
19 mins; January 29, 2026
Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
12 mins; January 29, 2026
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
14 mins; January 29, 2026
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
15 mins; January 29, 2026
Personalizing First-Line Therapy for CLL
16 mins; January 29, 2026
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
15 mins; January 29, 2026
Early Approaches to RAS Targeting: Efficacy Signals and Known Limitations
6 mins; January 28, 2026
Evaluating Use in Pancreatic Cancer: Efficacy and Safety Data for ON-State RAS Inhibitors
5 mins; January 28, 2026
Mechanistic Evolution in RAS Therapy: ON-State and Multi-Selective Targeting
5 mins; January 28, 2026
Novel RAS-Targeted Therapy: Prevention, Monitoring, and Mitigation of Adverse Events
6 mins; January 28, 2026
NSCLC Data Review: Efficacy and Safety Data for ON-State RAS Inhibitors
6 mins; January 28, 2026
RAS Across Tumors: Who to Test When
6 mins; January 28, 2026
RAS(ON) and Beyond: Clinical Integration and Strategic Sequencing
5 mins; January 28, 2026
Unmet Need: Second-Line Outcomes Remain Poor for NSCLC and Pancreatic Cancer
5 mins; January 28, 2026
Masterclass in Cardiac Amyloidosis: Disease Spectrum, Diagnosis and Management
2 mins; January 27, 2026
Frontline Insights: Emerging Therapeutic Strategies in HNSCC
14 mins; January 26, 2026
Breaking the Line: Moving Bispecific Antibodies Upstream in Treating Multiple Myeloma
12 mins; January 22, 2026
No Patient with CKD Left Behind! Emerging CKD Therapies in T1D
29 mins; January 15, 2026
Interdisciplinary Strategies for BRCA-Mutated EBC: Testing, Targeting, and Team-Based Care
45 mins; January 14, 2026
Oh, the Hats You'll Wear! The Many Modalities of Pediatric Obesity Management
56 mins; January 05, 2026
Addressing Unmet Needs in Metastatic Uveal Melanoma
59 mins; January 04, 2026
Spotlight on Systemic Sclerosis: Pathophysiology, Presentation, & Emerging Evidence
42 mins; January 04, 2026
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
55 mins; January 01, 2026
Case Review: Can You Crack This IBD Case?
6 mins; December 30, 2025
Case Review: Targets Are Met—Can You Stick the Landing?
7 mins; December 30, 2025
Diagnosing IBD: Is It IBD or Something Else? Can You Tell?
6 mins; December 30, 2025
IBD Immunopathogenesis: Do You Know What You're Blocking?
7 mins; December 30, 2025
Remission: Can You Prove It?
6 mins; December 30, 2025
Severity Assessment: Can You Pin the Stage on the Patient?
6 mins; December 30, 2025
Switching Strategies: Switch or Stay—What’s Your Call?
5 mins; December 30, 2025
Tailoring Treatment: Can You Select the Best Therapy?
6 mins; December 30, 2025
Treat-to-Target: Are We There Yet?
5 mins; December 30, 2025
Earlier Action, Lasting Impact: Closing the LDL-C Gap in Patients Without a Prior MACE
16 mins; December 29, 2025
Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline
57 mins; December 25, 2025
When Topicals Fail: The New IPC Consensus Every Clinician Should Know
13 mins; December 21, 2025
New Pathways in the Treatment of DMD
39 mins; December 18, 2025
All Sides of the Joint: Integrated TGCT Care Across Specialties
5 mins; December 14, 2025
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
4 mins; December 14, 2025
Beyond the Scalpel: When TGCT Surgery Isn’t the Solution
5 mins; December 14, 2025
Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R
4 mins; December 14, 2025
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
5 mins; December 14, 2025
Implementing the Latest Diagnostic and Treatment Approaches for Generalized Myasthenia Gravis
24 mins; December 14, 2025
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
5 mins; December 14, 2025
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
5 mins; December 14, 2025
The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT
5 mins; December 14, 2025
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
5 mins; December 14, 2025
Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
4 mins; December 14, 2025
Advances in Treatment of Hypoparathyroidism: Importance of Genetic Testing for Autosomal Dominant Hypocalcemia Type 1
22 mins; December 09, 2025
Taking Action Against RSV: No Child Unprotected
31 mins; December 03, 2025
Early Action in Obesity: Transforming Practice, Improving Outcomes
12 mins; December 02, 2025
Future mCRC Directions: Enhancing Anti-EGFR Therapy With Novel Combination Strategies
5 mins; December 01, 2025
Rethinking Schizophrenia Treatment Through Muscarinic Modulation
14 mins; December 01, 2025
IgAN Management Into Practice: Evolving Guidelines & Targeted Therapies
14 mins; November 18, 2025
Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
10 mins; November 17, 2025
MOA: CDH6-Targeted Antibody-Drug Conjugates
6 mins; November 13, 2025
Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies
6 mins; November 13, 2025
Looking Ahead: Integrating CDH6-Targeted Therapies Into Ovarian Cancer Treatment Paradigms
7 mins; November 13, 2025
Navigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer
5 mins; November 13, 2025
Safety and Tolerability of CDH6-Directed Antibody-Drug Conjugates
7 mins; November 13, 2025
The Fifth Pillar? Closing the Gap in HFrEF
29 mins; November 13, 2025
Treating MASH With Compensated Cirrhosis: A Serious Unmet Need
16 mins; November 10, 2025
Advancing Clinical Expertise in CELMoDs: Transforming Multiple Myeloma Treatment
42 mins; November 09, 2025
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
43 mins; November 06, 2025
Updates in Major Depressive Disorder with Insomnia
26 mins; November 06, 2025
The Hidden Threat: Transforming CKD Care Across the Diabetes Spectrum
22 mins; November 04, 2025
Case-Based Approach: Optimizing Cardio-Kidney-Metabolic Outcomes in Individuals With T2D & CKD
17 mins; October 30, 2025
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
14 mins; October 29, 2025
Mechanism-Driven gMG Therapy: FcRn Antagonists and the Rise of Precision Neurology
32 mins; October 28, 2025
CKD-aP: Beyond the Surface
5 mins; October 23, 2025
CKD-aP or Something Else? Decoding the Diagnosis
5 mins; October 23, 2025
CKD-aP Treatment Tool Kit
4 mins; October 23, 2025
Elevating CKD-aP Care: New Frontier
5 mins; October 23, 2025
Improving Sleep and Mental Health in Patients with CKD-aP
4 mins; October 23, 2025
Is CKD-aP Hiding in Your Dialysis Center?
6 mins; October 23, 2025
Kappa-Opioid Settings: Real-World Evidence Insights
4 mins; October 23, 2025
Quantifying CKD-aP: Tools for Better Care
5 mins; October 23, 2025
The Patient-Clinician Connection in Managing CKD-aP
7 mins; October 23, 2025
Diagnosing Minimal Hepatic Encephalopathy: There's an App for That?
4 mins; October 22, 2025
Hepatic Encephalopathy: An Ominous Sign
4 mins; October 22, 2025
Advances in the Treatment of Hepatic Encephalopathy
5 mins; October 22, 2025
Hepatic Encephalopathy: Tipping the Balance
4 mins; October 22, 2025
Hepatic Encephalopathy: Unmet Therapeutic Needs
5 mins; October 22, 2025
Hepatic Encephalopathy: What's Sarcopenia Got to Do With It?
4 mins; October 22, 2025
The Clinical Spectrum of Hepatic Encephalopathy
5 mins; October 22, 2025
Treatment of Overt Hepatic Encephalopathy
5 mins; October 22, 2025
You Can’t Diagnose MHE Unless You Diagnose Cirrhosis
5 mins; October 22, 2025
Not Just a Headache: Migraine Across Women’s Lifespan
52 mins; October 22, 2025
ENDOVOICE Live: Endometriosis—A Chronic Burden of Reproductive Years
57 mins; October 21, 2025
Click here to see more
‹ Prev
1
2
3
4
5
…
8
Next ›
